Michael A Makara1, Jerry Curran1, Sean C Little1, Hassan Musa1, Iuliia Polina1, Sakima A Smith1, Patrick J Wright1, Sathya D Unudurthi1, Jed Snyder1, Vann Bennett1, Thomas J Hund1, Peter J Mohler2. 1. From The Dorothy M. Davis Heart & Lung Research Institute (M.A.M., J.C., S.C.L., H.M., I.P., S.A.S., P.J.W., S.D.U., J.S., T.J.H., P.J.M. ), Departments of Internal Medicine (S.A.S., P.J.M.), and Physiology and Cell Biology (M.A.M., J.C., S.C.L., H.M., I.P., S.A.S., P.J.W., P.J.M.), The Ohio State University Wexner Medical Center, Columbus; Department of Biomedical Engineering, The Ohio State University College of Engineering, Columbus (S.D.U., J.S., T.J.H.); and Howard Hughes Medical Institute, Department of Biochemistry, Duke University Medical Center, Durham, NC (V.B.). 2. From The Dorothy M. Davis Heart & Lung Research Institute (M.A.M., J.C., S.C.L., H.M., I.P., S.A.S., P.J.W., S.D.U., J.S., T.J.H., P.J.M. ), Departments of Internal Medicine (S.A.S., P.J.M.), and Physiology and Cell Biology (M.A.M., J.C., S.C.L., H.M., I.P., S.A.S., P.J.W., P.J.M.), The Ohio State University Wexner Medical Center, Columbus; Department of Biomedical Engineering, The Ohio State University College of Engineering, Columbus (S.D.U., J.S., T.J.H.); and Howard Hughes Medical Institute, Department of Biochemistry, Duke University Medical Center, Durham, NC (V.B.). peter.mohler@osumc.edu.
Abstract
RATIONALE: Nav1.5 (SCN5A) is the primary cardiac voltage-gated Nav channel. Nav1.5 is critical for cardiac excitability and conduction, and human SCN5A mutations cause sinus node dysfunction, atrial fibrillation, conductional abnormalities, and ventricular arrhythmias. Further, defects in Nav1.5 regulation are linked with malignant arrhythmias associated with human heart failure. Consequently, therapies to target select Nav1.5 properties have remained at the forefront of cardiovascular medicine. However, despite years of investigation, the fundamental pathways governing Nav1.5 membrane targeting, assembly, and regulation are still largely undefined. OBJECTIVE: Define the in vivo mechanisms underlying Nav1.5 membrane regulation. METHODS AND RESULTS: Here, we define the molecular basis of an Nav channel regulatory platform in heart. Using new cardiac-selective ankyrin-G(-/-) mice (conditional knock-out mouse), we report that ankyrin-G targets Nav1.5 and its regulatory protein calcium/calmodulin-dependent kinase II to the intercalated disc. Mechanistically, βIV-spectrin is requisite for ankyrin-dependent targeting of calcium/calmodulin-dependent kinase II-δ; however, βIV-spectrin is not essential for ankyrin-G expression. Ankyrin-G conditional knock-out mouse myocytes display decreased Nav1.5 expression/membrane localization and reduced INa associated with pronounced bradycardia, conduction abnormalities, and ventricular arrhythmia in response to Nav channel antagonists. Moreover, we report that ankyrin-G links Nav channels with broader intercalated disc signaling/structural nodes, as ankyrin-G loss results in reorganization of plakophilin-2 and lethal arrhythmias in response to β-adrenergic stimulation. CONCLUSIONS: Our findings provide the first in vivo data for the molecular pathway required for intercalated disc Nav1.5 targeting/regulation in heart. Further, these new data identify the basis of an in vivo cellular platform critical for membrane recruitment and regulation of Nav1.5.
RATIONALE: Nav1.5 (SCN5A) is the primary cardiac voltage-gated Nav channel. Nav1.5 is critical for cardiac excitability and conduction, and humanSCN5A mutations cause sinus node dysfunction, atrial fibrillation, conductional abnormalities, and ventricular arrhythmias. Further, defects in Nav1.5 regulation are linked with malignant arrhythmias associated with humanheart failure. Consequently, therapies to target select Nav1.5 properties have remained at the forefront of cardiovascular medicine. However, despite years of investigation, the fundamental pathways governing Nav1.5 membrane targeting, assembly, and regulation are still largely undefined. OBJECTIVE: Define the in vivo mechanisms underlying Nav1.5 membrane regulation. METHODS AND RESULTS: Here, we define the molecular basis of an Nav channel regulatory platform in heart. Using new cardiac-selective ankyrin-G(-/-) mice (conditional knock-out mouse), we report that ankyrin-G targets Nav1.5 and its regulatory protein calcium/calmodulin-dependent kinase II to the intercalated disc. Mechanistically, βIV-spectrin is requisite for ankyrin-dependent targeting of calcium/calmodulin-dependent kinase II-δ; however, βIV-spectrin is not essential for ankyrin-G expression. Ankyrin-G conditional knock-out mouse myocytes display decreased Nav1.5 expression/membrane localization and reduced INa associated with pronounced bradycardia, conduction abnormalities, and ventricular arrhythmia in response to Nav channel antagonists. Moreover, we report that ankyrin-G links Nav channels with broader intercalated disc signaling/structural nodes, as ankyrin-G loss results in reorganization of plakophilin-2 and lethal arrhythmias in response to β-adrenergic stimulation. CONCLUSIONS: Our findings provide the first in vivo data for the molecular pathway required for intercalated disc Nav1.5 targeting/regulation in heart. Further, these new data identify the basis of an in vivo cellular platform critical for membrane recruitment and regulation of Nav1.5.
Authors: Dao W Wang; Prakash C Viswanathan; Jeffrey R Balser; Alfred L George; D Woodrow Benson Journal: Circulation Date: 2002-01-22 Impact factor: 29.690
Authors: Brenda Gerull; Arnd Heuser; Thomas Wichter; Matthias Paul; Craig T Basson; Deborah A McDermott; Bruce B Lerman; Steve M Markowitz; Patrick T Ellinor; Calum A MacRae; Stefan Peters; Katja S Grossmann; Jörg Drenckhahn; Beate Michely; Sabine Sasse-Klaassen; Walter Birchmeier; Rainer Dietz; Günter Breithardt; Eric Schulze-Bahr; Ludwig Thierfelder Journal: Nat Genet Date: 2004-10-17 Impact factor: 38.330
Authors: Peter J Mohler; Jean-Jacques Schott; Anthony O Gramolini; Keith W Dilly; Silvia Guatimosim; William H duBell; Long-Sheng Song; Karine Haurogné; Florence Kyndt; Mervat E Ali; Terry B Rogers; W J Lederer; Denis Escande; Herve Le Marec; Vann Bennett Journal: Nature Date: 2003-02-06 Impact factor: 49.962
Authors: Daniela Ponce-Balbuena; Guadalupe Guerrero-Serna; Carmen R Valdivia; Ricardo Caballero; F Javier Diez-Guerra; Eric N Jiménez-Vázquez; Rafael J Ramírez; André Monteiro da Rocha; Todd J Herron; Katherine F Campbell; B Cicero Willis; Francisco J Alvarado; Manuel Zarzoso; Kuljeet Kaur; Marta Pérez-Hernández; Marcos Matamoros; Héctor H Valdivia; Eva Delpón; José Jalife Journal: Circ Res Date: 2018-03-07 Impact factor: 17.367
Authors: Sakima A Smith; Langston D Hughes; Crystal F Kline; Amber N Kempton; Lisa E Dorn; Jerry Curran; Michael Makara; Tyler R Webb; Patrick Wright; Niels Voigt; Philip F Binkley; Paul M L Janssen; Ahmet Kilic; Cynthia A Carnes; Dobromir Dobrev; Matthew N Rasband; Thomas J Hund; Peter J Mohler Journal: Am J Physiol Heart Circ Physiol Date: 2016-04-22 Impact factor: 4.733
Authors: Sakima A Smith; Amy C Sturm; Jerry Curran; Crystal F Kline; Sean C Little; Ingrid M Bonilla; Victor P Long; Michael Makara; Iuliia Polina; Langston D Hughes; Tyler R Webb; Zhiyi Wei; Patrick Wright; Niels Voigt; Deepak Bhakta; Katherine G Spoonamore; Chuansheng Zhang; Raul Weiss; Philip F Binkley; Paul M Janssen; Ahmet Kilic; Robert S Higgins; Mingzhai Sun; Jianjie Ma; Dobromir Dobrev; Mingjie Zhang; Cynthia A Carnes; Matteo Vatta; Matthew N Rasband; Thomas J Hund; Peter J Mohler Journal: Circulation Date: 2015-01-28 Impact factor: 29.690
Authors: Christine A Klemens; Robert S Edinger; Lindsay Kightlinger; Xiaoning Liu; Michael B Butterworth Journal: J Biol Chem Date: 2016-11-28 Impact factor: 5.157
Authors: Hassan Musa; Crystal F Kline; Amy C Sturm; Nathaniel Murphy; Sara Adelman; Chaojian Wang; Haidun Yan; Benjamin L Johnson; Thomas A Csepe; Ahmet Kilic; Robert S D Higgins; Paul M L Janssen; Vadim V Fedorov; Raul Weiss; Christina Salazar; Thomas J Hund; Geoffrey S Pitt; Peter J Mohler Journal: Proc Natl Acad Sci U S A Date: 2015-09-21 Impact factor: 11.205